Macroview Investment Management LLC Organon & Co. Transaction History

Macroview Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$10.95 - $17.32 $3,098 - $4,901	-283 Reduced 91.0%	28 $0
Q3 2023 Oct 26, 2023	BUY	$16.59 - $23.77 $4,694 - $6,726	283 Added 1010.71%	311 $5,000
Q2 2023 Jul 13, 2023	SELL	$19.27 - $24.63 $173 - $221	-9 Reduced 24.32%	28 $0
Q2 2022 Jul 20, 2022	BUY	$31.66 - $38.9 $284 - $350	9 Added 32.14%	37 $1,000
Q2 2021 Jul 23, 2021	BUY	$28.45 - $38.0 $796 - $1,064	28 New	28 $1,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.